Expanded Access to Velmanase Alfa

NCT04959240 · clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chiesi Farmaceutici S.p.A.